L3VLUP
ProSign in

RXRX in the 13F filings

Recursion Pharmaceuticals Inc · CUSIP 75629V104

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Mar 2026
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 8 May 2026
Managers listing it
27
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q4 2025 and Q1 2026; 2 listed it in both
Shares listed
87,131,208
combined, among listed positions
Reported value
$268m
combined, at the quarter end

AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.

Among the 91 comparable managers: 17 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +4,055,736.

Managers listing RXRX in Q1 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2025, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

27 of 27 holders

ActionFiling
ARK Investment Management LLC40,212,769$123m0.96%Added+2,895,91312 May 2026 (the filing on sec.gov)
Baillie Gifford & Co23,675,407$73m0.07%Trimmed-99,5658 May 2026 (the filing on sec.gov)
Susquehanna International Group LLP4,225,277$13munder 0.1%Trimmed-170,82715 May 2026 (the filing on sec.gov)
Two Sigma Investments LP4,066,315$12munder 0.1%Added+991,19215 May 2026 (the filing on sec.gov)
Marshall Wace LLP2,876,928$8.8munder 0.1%Added+2,650,31915 May 2026 (the filing on sec.gov)
Millennium Management LLC2,612,277$8.0munder 0.1%Added+1,116,43815 May 2026 (the filing on sec.gov)
Renaissance Technologies LLC2,400,605$7.4munder 0.1%Newnew14 May 2026 (the filing on sec.gov)
Man Group PLC1,199,563$3.7munder 0.1%Added+1,171,60315 May 2026 (the filing on sec.gov)
Fidelity (FMR LLC)736,654$2.3munder 0.1%Trimmed-2,505,23815 May 2026 (the filing on sec.gov)
Invesco Ltd691,153$2.1munder 0.1%Added+165,00912 May 2026 (the filing on sec.gov)
Citadel Advisors LLC624,659$1.9munder 0.1%Trimmed-3,605,34015 May 2026 (the filing on sec.gov)
AllianceBernstein LP457,504$1.9munder 0.1%Added+96,13015 May 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc560,746$1.7munder 0.1%Added+145,38315 May 2026 (the filing on sec.gov)
Hudson Bay Capital Management LP535,730$1.6munder 0.1%Added+110,73013 May 2026 (the filing on sec.gov)
Verition Fund Management LLC412,747$1.3munder 0.1%Held015 May 2026 (the filing on sec.gov)
ExodusPoint Capital Management LP346,750$1.1munder 0.1%Trimmed-45,05114 May 2026 (the filing on sec.gov)
Tudor Investment Corp265,296$814kunder 0.1%Newnew15 May 2026 (the filing on sec.gov)
AQR Capital Management LLC244,391$750kunder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Janus Henderson Group Ltd220,309$675kunder 0.1%Added+82,10018 May 2026 (the filing on sec.gov)
Balyasny Asset Management LLC167,048$513kunder 0.1%Trimmed-501,12615 May 2026 (the filing on sec.gov)
Wellington Management Group LLP151,419$465kunder 0.1%Trimmed-1,19715 May 2026 (the filing on sec.gov)
Brevan Howard Capital Management LP133,315$409kunder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Winton Group Ltd104,100$320kunder 0.1%Newnew12 May 2026 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC84,556$260kunder 0.1%Newnew15 May 2026 (the filing on sec.gov)
Squarepoint Ops LLC52,988$163kunder 0.1%Trimmed-834,01615 May 2026 (the filing on sec.gov)
Page 1 of 2

Largest increases and reductions, by shares

Q4 2025 to Q1 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (6)

Exited (3)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
3 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

012320222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
RXRX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20212$763mn.a.n.a.
Q3 20212$567mn.a.n.a.
Q4 20212$417mn.a.n.a.
Q1 20222$178mn.a.n.a.
Q2 20222$193mn.a.n.a.
Q3 20222$266mn.a.n.a.
Q4 20222$215mn.a.n.a.
Q1 20232$192mn.a.n.a.
Q2 20232$223mn.a.n.a.
Q3 20232$240mn.a.n.a.
Q4 20232$442m11
Q1 20242$485m11
Q2 20243$415m30
Q3 20243$387m21
Q4 20242$387m02
Q1 20253$315m21
Q2 20252$289m02
Q3 20252$281m11
Q4 20252$250m188
Q1 20262$196m1712
Q2 20262$238m1314

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

RXRX and GILD →RXRX and AMGN →RXRX and ARGX →Choose a stock to compare with RXRX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own RXRX, latest filings →Back to the 13F Explorer →